NCT04401436View on ClinicalTrials.gov

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

February 20, 2025

Study Completion Date

February 24, 2025

Conditions
Coronavirus Disease 2019
Trial Locations (3)

20007

MedStar Georgetown University Hospital, Washington D.C.

20010

MedStar Health Research Institute: Washington Hospital Medical Center, Washington D.C.

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04401436 - COVID-19 Associated Lymphopenia Pathogenesis Study in Blood | Biotech Hunter | Biotech Hunter